摘要
经过两年多透彻的伦理性及科学性检查之后.身处哈佛与波士顿儿童医院的哈佛千细胞研究所(HSCI)研究员已经获许开展使用体细胞核转移(SCNT)的实验来创建疾病特异干细胞系。其目标是开发出新的疗法,使大量患有目前不能治愈疾病的人们免遭痛苦。
After more than two years of intensive ethical and scientific review, Harvard Stem Cell Institute (HSCI) researchers at Harvard and Children's Hospital Boston have been cleared to begin experiments using somatic cell nuclear transfer (SCNT) to create disease-specific stem cell lines. The aim is to develop treatments for a wide range of now-incurable conditions afflicting tens of millions of people.